NEW INSULIN FOR DIABETICS ON PERSONS WITH OVERWEIGHT

摘要

A new insulin containing only 2 chains, the B-chain and the P-peptide, which prevents the complications that diabetics usually suffer from, and prevents obesity, especially in the stomach area. Despite the research on diabetes nothing has changed for more than 60 years, except the technical function of the needle and the production of the insulin pump. The problem with the resulting complications has not been solved; it has only been possible to treat the symptoms of for example kidney troubles and problems with the eyesight. The new insulin can, according to the description in the patent, be taken in 3 times as high dose as normal, without any resulting complications, in contradistinction to the old insulin. The new insulin is very fitting for use in an insulin pump, and the patient will not suffer from any ill-effects from an overdose of insulin, since the energy will stay in the blood circulation. Since it is the A-chain as primarily cause obesity and since the new insulin does not contain the A-chain, it will prevents from obesity in the stomach area. The P-peptide ends with the amino acid L-arginine, which widen the blood vessels in the abdomen and make them receptive to the growth hormone, which decrease the obesity in the abdomen.